Impact of cardiovascular risk factors on severity of peripheral artery disease.

[1]  M. Mangiafico,et al.  Arterial Plaques in Peripheral Arteries Diagnosed by Ultrasound in a Cohort of Patients With Type 2 Diabetes Mellitus , 2015, Angiology.

[2]  R. J. Valentine,et al.  The need for improved risk stratification in chronic critical limb ischemia. , 2014, Journal of vascular surgery.

[3]  T. Dawber,et al.  The Framingham Study , 2014 .

[4]  Igor Rudan,et al.  Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis , 2013, The Lancet.

[5]  R. J. Valentine,et al.  Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia. , 2013, Journal of vascular surgery.

[6]  Iryna Lobach,et al.  Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. , 2012, Journal of vascular surgery.

[7]  M. M. Joosten,et al.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. , 2012, JAMA.

[8]  A. Gomes,et al.  A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. , 2012, Circulation.

[9]  A. Davies,et al.  Chapter I: Definitions, epidemiology, clinical presentation and prognosis. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[10]  L. Norgren,et al.  Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia , 2011, The Lancet.

[11]  U. Eisenberger,et al.  Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization. , 2011, Journal of vascular surgery.

[12]  Deepak L. Bhatt,et al.  Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States , 2010, Circulation. Cardiovascular quality and outcomes.

[13]  Richard Barnett.  Diabetes , 1904, The Lancet.

[14]  A. Köttgen,et al.  Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. , 2009, European heart journal.

[15]  Deepak L. Bhatt,et al.  Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. , 2009, Atherosclerosis.

[16]  S. Kownator,et al.  Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study , 2009, International journal of clinical practice.

[17]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[19]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[20]  Beatrice A. Golomb,et al.  Peripheral Arterial Disease: Morbidity and Mortality Implications , 2006, Circulation.

[21]  J. Schmidli,et al.  Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[22]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[23]  C. Fox,et al.  High Prevalence of Peripheral Arterial Disease in Persons With Renal Insufficiency: Results From the National Health and Nutrition Examination Survey 1999–2000 , 2004, Circulation.

[24]  J. Allenberg,et al.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. , 2004, Atherosclerosis.

[25]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[27]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  G. Lowe,et al.  Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. , 1999, European heart journal.

[29]  R B D'Agostino,et al.  Intermittent claudication. A risk profile from The Framingham Heart Study. , 1997, Circulation.

[30]  R. Prescott,et al.  Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. , 1992, American journal of epidemiology.

[31]  W. Kannel,et al.  Diabetes, Intermittent Claudication, and Risk of Cardiovascular Events: The Framingham Study , 1989, Diabetes.

[32]  H G Korvin,et al.  Intermittent claudication. , 1971, British medical journal.